Putting for Parkinson s Presents $27,000 to the UC Gardner Center
On Feb. 1, Putting for Parkinsons presented a check for $27,000 to members of the University of Cincinnati (UC) James J. and Joan A. Gardner Family Center for Parkinsons Disease and Movement Disorders to support ongoing Parkinsons research at UC and the center.
Scott and Joy Layman, of Fort Thomas, Kentucky, are the founders of Putting for Parkinsons, an annual golf event held at Highland Country Club which raises awareness and funds for research of Parkinsons. Scott was diagnosed with Parkinsons at age 43, after he began experiencing shaking hands, impaired speech and balance issues. Scott says that he is hopeful that the money donated to UCs Gardner Center is a means to an end to find a cure of Parkinsons disease.
"Dr. Espay and the team of physicians who see me at the Gardner Center are like part of our family now, he says of the relationships formed over the years.
Now in its ninth year, Putting for Parkinsons has raised more than $230,000 and has benefitted Parkinsons research at UC as well as provided support to specific individuals with Parkinsons in need of special medical devices or home equipment. "When I was diagnosed, I had been very fortunate in my professional situation. For Parkinsons patients who dont have that, we wanted to help in that regard, says Scott, of the additional proceeds donated each year to one or two deserving individuals with Parkinsons disease.
The date for this years Putting for Parkinsons is set for July 13, 2018. For more information, visit putting4parkinsons.com.
Scott Layman, center, and his wife Joy, present the funds raised from the 2017 Putting for Parkinson's to Alberto Espay, MD, Director of the Gardner Center for Parkinson's Disease and Movement Disorder
Tags
Related Stories
Cancer Center plays key role in lab research, clinical trials for new pancreatic cancer drug
September 1, 2026
WLWT and WCPO highlighted the contributions of University of Cincinnati Cancer Center researchers that helped lead to the recent FDA approval of daraxonrasib, a new treatment for pancreatic cancer.
Cancer Center physician receives $150,000 New Investigator Research Grant to study treatment-resistant leukemia
September 1, 2026
The University of Cincinnati Cancer Center’s Sarah Skuli, MD, PhD, received a two‑year, $150,000 Leukemia Research Foundation New Investigator Grant to study TP53‑mutated leukemia, a treatment‑resistant subtype with very poor outcomes.
Heavy social media use linked to depression
August 31, 2026
U.S. News and World Report, Yahoo! News, MSN, USA Today and other national media highlight a new study by the University of Cincinnati and Northwestern University that found a correlation between heavy social media use and depression in adults.